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Abstract
Although it has generally been assumed that protein kinase A (PKA) is essential for brown adipose tissue function, this has
not as yet been clearly demonstrated. H89, an inhibitor of PKA, was used here to inhibit PKA activity. In cell extracts, it was
confirmed that norepinephrine stimulated PKA activity, which was abolished by H89 treatment. In isolated brown
adipocytes, H89 inhibited adrenergically induced thermogenesis (with an IC50 of approx. 40 WM), and in cultured cells,
adrenergically stimulated expression of the uncoupling protein-1 (UCP1) gene was abolished by H89 (full inhibition with 50
WM). However, H89 has been reported to be an adrenergic antagonist on L1/L2-adrenoceptors (AR). Although adrenergic
stimulation of thermogenesis and UCP1 gene expression are mediated via L3-ARs, it was deemed necessary to investigate
whether H89 also had antagonistic potency on L3-ARs. It was found that EC50 values for L3-AR-selective stimulation of
cAMP production (with BRL-37344) in brown adipose tissue membrane fractions and in intact cells were not affected by
H89. Similarly, the EC50 of adrenergically stimulated oxygen consumption was not affected by H89. As H89 also abolished
forskolin-induced UCP1 gene expression, and potentiated selective L3-AR-induced cAMP production, H89 must be active
downstream of cAMP. Thus, no antagonism of H89 on L3-ARs could be detected. We conclude that H89 can be used as a
pharmacological tool for elucidation of the involvement of PKA in cellular signalling processes regulated via L3-ARs, and
that the results are concordant with adrenergic stimulation of thermogenesis and UCP1 gene expression in brown adipocytes
being mediated via a PKA-dependent pathway. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
L3-Adrenergic e¡ects are highly important for
brown adipose tissue function, both acutely (thermo-
genesis) [1,2] and chronically (expression of the un-
coupling protein-1 (UCP1) gene) [3]. Activation of
L3-adrenoceptors (L-ARs) on brown adipocytes in-
creases intracellular cAMP levels [4], which is be-
lieved to activate protein kinase A (PKA), which
then presumably activates lipolysis and thermogene-
sis [5,6] and Ucp1 expression [7]. However, PKA in-
volvement has never been directly demonstrated. In
reality, the only evidence for involvement of PKA in
the mediation of the L3-adrenergic signal is that ad-
renergic stimulation of thermogenesis and Ucp1 ex-
pression can be mimicked by increases in cAMP lev-
els [2,3]. Thus, the assumption of an involvement of
PKA may be questioned on two grounds. One is that
the ability of a substance to mimic a function is not
evidence that it is the physiological mediating agent.
Indeed, L3-adrenergic pathways not involving in-
creases in cAMP levels have been described [8,9],
and thermogenesis and Ucp1 expression could be
mediated via such pathways, even though cAMP
can mimic the adrenergic stimulation. The second is
that the tenet that cellular responses stimulated via
increased cAMP levels are exclusively mediated via
PKA activation is no longer valid. Recent ¢ndings
have demonstrated that cAMP can also signal via
other cellular mediators [10^19]. Therefore, to inves-
tigate whether PKA actually mediates the L3-adren-
ergic stimulation of Ucp1 expression and thermogen-
esis, we attempted to inhibit PKA activity in
norepinephrine (NE)-stimulated brown adipocytes.
One established inhibitor of PKA is N-[2-(p-
bromocinnamylamino)ethyl]-5-isoquinolinesulphona-
mide (H89) [20,21]. However, unspeci¢c e¡ects of
cellular inhibitors can compromise the interpretation
of results obtained. In this respect, it has recently
been reported that H89 also functions as a direct
competitive adrenergic antagonist on L1- and L2-
ARs [22]. While this clearly severely reduces its use-
fulness as a tool in investigations of L1- and L2-ad-
renergic signalling mechanisms, it also leads to ap-
prehension that H89 could be an antagonist also for
the third L-adrenoceptor, the L3-AR. This possibility
has not as yet been investigated, but an examination
of this issue is evidently essential for further use of
H89 in investigations of L3-AR signalling in brown
adipocytes and in other cells and tissues possessing
L3-ARs.
In the present study, we have therefore also inves-
tigated the possible antagonistic e¡ect of H89 on L3-
ARs. We conclude that H89 has no antagonistic po-
tency for L3-ARs. Rather, H89 appears to be a sat-
isfactory inhibitor of the adrenergically induced
pathways earlier anticipated, and herein shown to,
progress through PKA activation in these cells,
such as stimulation of thermogenesis and Ucp1 ex-
pression.
2. Materials and methods
2.1. Cell culture
Brown adipocyte precursors were isolated from 3^
4-week old mice of the NMRI strain, obtained from
a local supplier (Eklunds), principally as described by
Ne¤chad et al. [23] with modi¢cations as described
earlier [24,25].
The cells were cultured in Costar 6-well or 12-well
plates, as detailed in Fredriksson et al. [25]. The cul-
ture medium was that described earlier [24,25] (prin-
cipally Dulbecco’s modi¢ed Eagle’s medium
(DMEM) with 10% newborn calf serum), and the
cells were cultured at 37‡C in a water-saturated at-
mosphere of 8% CO2 in air in a Heraeus CO2-auto-
zero B5061 incubator. On day 1, the cultures were
washed with prewarmed DMEM, and fresh pre-
warmed medium was then added. Medium was
then routinely changed every other day until the
day of experimentation, which was day 5^6.
2.2. Analysis of PKA activity
After stimulation of cell cultures, protein extracts
were isolated. Brie£y, each culture dish was rinsed
with PBS and cells were collected by scraping in
0.5 ml of extraction bu¡er (25 mM Tris-HCl,
0.5 mM EDTA, 0.5 mM EGTA, 10 mM L-mercap-
toethanol, 1 Wg/ml leupeptin, 1 Wg/ml aprotinin and
0.5 mM PMSF). The suspension was homogenised
by sucking through a 23G needle ten times. It was
then centrifuged 5 min at 14 000Ug, after which the
supernatant was collected and 5 Wl aliquots were
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used to quantify PKA activity with the SignaTECT
cAMP-Dependent PKA Assay System (Promega) ac-
cording to the manufacturer’s instructions. Brie£y, in
this assay, incorporation of [Q-32P]ATP into a bio-
tinylated peptide (LRRASLG), a highly speci¢c sub-
strate for PKA, was analysed by scintillation count-
ing after incubation of the sample and peptide in the
presence of 100 WM ATP (with the labelled ATP
included). Some of these incubations were performed
in the presence of 50 WM H89. The activity of each
extract was normalised to the total activity of that
extract induced by addition of 5 WM cAMP to a
separate incubation.
2.3. Analysis of cAMP levels in cultured cells
After stimulation of cell cultures for 15 min, the
culture medium was aspirated and the cells were
treated principally as described earlier [4]. Brie£y,
0.8 ml 75% ethanol with 1 mM EDTA was added
to each well, and after 10 min, the cells were har-
vested by scraping. Ethanol was removed by Speed-
Vac centrifugation and the pellets were suspended in
0.5 ml 4UTE bu¡er and sonicated 5 s. After centri-
fugation, a 25 Wl supernatant aliquot from each sam-
ple was used for determination of cAMP levels with
the Cyclic AMP Assay System (Amersham), accord-
ing to the manufacturer’s instructions.
2.4. RNA isolation and analysis of mRNA levels
After stimulation of cell cultures, the culture me-
dium was discarded and the cells were dissolved in
0.8 ml of an Ultraspec solution (Biotecx), and the
manufacturer’s procedure for RNA isolation was fol-
lowed. 10 Wg of total RNA was separated by electro-
phoresis in an ethidium bromide-containing agarose-
formaldehyde gel, as described earlier [4,25]. The in-
tensity of the 18S and 28S rRNA bands under UV
light was checked to verify that all samples were
equally loaded and that no RNA degradation had
occurred. mRNA levels were analysed by Northern
blotting as described earlier [4,25].
The UCP1 and L-actin cDNAs were those used
earlier [3]. The probes were labelled with
[K-32P]dCTP with Ready To Go DNA labelling
beads (Amersham Pharmacia Biotech), according to
the manufacturer’s instructions.
2.5. Preparation of membrane fractions
A membrane fraction of brown adipose tissue was
prepared from adult Syrian hamsters living at room
temperature. The interscapular and cervical depots of
brown adipose tissue were minced in bu¡er (Tris-
HCl/Tris-Base 50 mM, MgCl2 10 mM, ascorbic
acid 0.5 mM, EDTA 1 mM, PMSF 0.1 mM; pH
was adjusted to 7.4 with NaOH) supplemented with
0.25 M sucrose, and homogenised in a Potter-Elve-
hjem homogeniser; this and the following procedures
were performed at about 4‡C. The homogenate was
centrifuged for 10 min at 9200Ug, the fat layer was
removed and the supernatant was ¢ltered through
one layer of silk cloth. The supernatant was then
centrifuged in sucrose bu¡er for 30 min at
100 000Ug, the pellet was homogenised again and
centrifuged at the same speed once more, in bu¡er
without sucrose. After this centrifugation, the pellet
was rehomogenised in bu¡er and ¢ltered again
through silk cloth. The membrane homogenate was
resuspended to about 3 mg protein/ml and then
stored at 380‡C. Protein concentration was deter-
mined by the method of Bradford, with bovine se-
rum albumin as standard.
2.6. Analysis of cAMP production in membrane
fractions
The cAMP assay was performed in an assay mix
of 90 Wl containing: ATP 0.5 mM, MgCl2 10 mM,
creatine phosphate 10 mM, creatine kinase 50 units/
ml, theophylline 2 mM, dithiothreitol 1 mM, in Tris-
Base 25 mM; pH 7.4, adjusted with HCl. To each
assay tube, 60 Wl membrane fraction (1 mg protein/
ml) was added together with agents as described.
After incubation at 37‡C for 10 min, the assay tubes
were boiled for 5 min, put on ice and centrifuged. A
supernatant aliquot (50 Wl) was taken from each in-
cubation tube and cAMP levels were determined
with the Cyclic AMP Assay System (Amersham), ac-
cording to the manufacturer’s instructions.
2.7. Measurement of oxygen consumption in freshly
isolated cells
Brown adipocytes were isolated from Syrian ham-
sters of both sexes (about 35 weeks old), principally
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as described earlier, by collagenase digestion of
pooled brown adipose tissue depots [26]. The cells
were counted in a Bu«rker chamber. Samples with
the intended amount of cells for each experiment
were taken from a concentrated cell suspension. Ex-
periments were also performed with cells from
NMRI mice (about 10 week old males), as indicated
in the text.
The oxygen consumption rates of the isolated
brown adipocytes were monitored with a Clark-
type oxygen electrode, as described previously [27].
80 000^100 000 cells were added to a magnetically
stirred oxygen electrode chamber thermostatted to
37‡C, containing Krebs-Ringer bicarbonate bu¡er
[26]. The cells were incubated with the indicated con-
centrations of H89, or with water addition for the
controls, for 10 min before the chamber was closed.
After registration of the basal rate of oxygen con-
sumption for 5 min, norepinephrine was added cu-
mulatively in increasing concentrations. Additions
were made with a Hamilton syringe through a small
hole in the cover of the chamber. The oxygen con-
sumption rate was then calculated as described ear-
lier [26,28].
2.8. Chemicals
H89 (Calbiochem), BRL-37344 (SmithKline Bee-
cham), norepinephrine ((3)-Arterenol bitartrate;
Sigma) and CGP-12177 (CGP-12177A; Ciba-Geigy)
were dissolved in water. Forskolin (Sigma) and lauric
acid (Schuchardt, Munich) were dissolved in dimeth-
yl sulphoxide (Sigma); ¢nal concentration in assay
was maximally 0.1%.
3. Results
3.1. PKA is activated by norepinephrine in primary
brown adipocyte cultures
The increase in cAMP levels observed in brown
adipocytes after adrenergic stimulation [4,25,29] is
expected to induce an activation of PKA. To verify
that PKA is activated in the cell system utilised here,
we determined the activity of PKA in cell extracts
from cultured brown adipocytes stimulated with
NE. PKA was activated by NE in a dose-dependent
manner (Fig. 1A). This observation in primary
brown adipocytes in culture is principally in agree-
ment with what has been demonstrated in slices of
brown adipose tissue [30] and in a human brown
adipocyte-like cell line [31], but it is in contrast to
an observation in immortalised di¡erentiated brown
adipocytes, in which adrenergic stimulation unex-
pectedly slightly decreased basal PKA activity [32].
3.2. E¡ect of H89 on activity of PKA from brown
adipocytes
To con¢rm that H89 was indeed able to inhibit
PKA extracted from brown adipocytes, the cells
were stimulated with NE, and PKA activity was an-
alysed in extracts from these cells. When added to
the cell extracts, H89 reduced the basal PKA activity
and abolished the NE-induced PKA activity (Fig.
1B). The maximal PKA activity, i.e. that induced
by addition of an excess of cAMP to the cell extracts,
was also fully abolished by H89; only 7% of the
activity remained (not shown; P6 0.0001, Student’s
paired t-test with six experiments). Thus, as expected,
H89 e¡ectively inhibited NE-induced PKA activity in
extracts of brown adipocytes.
3.3. E¡ect of H89 on the kinetics of cAMP
production stimulated via L3-adrenoceptors
To ascertain that possible inhibiting e¡ects of H89
on cellular functions were not caused by L3-adreno-
receptor antagonism, this issue was investigated in
membrane fractions.
The method of choice to investigate whether the
adrenergic antagonistic property of H89 reported for
L1- and L2-ARs [22] also applied to L3-ARs would
seem to be receptor binding studies. However, two
problems exist: ¢rst, no established, high a⁄nity ra-
dioactively labelled ligand exists for L3-ARs. Second,
and more importantly, receptor binding studies do
not address the signalling function of the receptor.
Therefore, we analysed the e¡ect of H89 on the ki-
netics of L3-AR-mediated induction of cAMP pro-
duction in membrane fractions isolated from brown
adipose tissue. In such crude membrane fractions, L3-
ARs are potent, although probably not exclusive,
stimulators of adenylyl cyclase activity [33,34], but
the use of L3-AR-selective agonists ensured that it
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was only L3-AR responses that were investigated.
The L3-AR-selective agonist BRL-37344 induced a
3.3-fold increase in cAMP levels in brown adipose
tissue membranes, with an EC50 of 141 þ 24 nM
(Fig. 2A).
A competitive adrenergic antagonistic e¡ect of
H89 on L3-ARs would be expected to lead to a shift
in the kinetics to a markedly higher EC50 value. Re-
ported Ki values for L1- and L2-AR antagonism by
H89 are 350 nM and 180 nM, respectively [22]. If a
similar antagonistic potency of H89 were to exist for
L3-ARs (with a Ki of around 0.2 WM), an H89 con-
centration of 50 WM, as used here, would be expected
to lead to an increase in the EC50 value by approx.
250-fold (EC50 (with H89) = EC50U(1+(50 WM/0.2
WM))), i.e. to an apparent EC50 of about 35 WM.
However, as seen in Fig. 2B, in the presence of
50 WM H89 there was no increase in the EC50 value.
Rather, a slight but insigni¢cant decrease was ob-
served: the EC50 was 116 þ 8 nM. Thus, no adrener-
gic antagonistic e¡ect of H89 could be detected in
membrane fractions of brown adipose tissue stimu-
lated via L3-ARs.
To substantiate this conclusion, we performed sim-
ilar experiments in intact cultured brown adipocytes.
In these di¡erentiated brown adipocytes, the L3-AR
is the only L-AR coupled to cAMP production [4]
and thus this model system could be considered a
pure L3 system, in contrast to the membrane frac-
tions. In these cells, BRL-37344 potently induced
cAMP production to 40-fold that of basal levels,
with an EC50 of 17 þ 7 nM (Fig. 3A), in agreement
with earlier reports [4]. Calculated as above, an an-
tagonistic potency of H89 for L3-ARs similar to that
for L1- and L2-ARs would shift the EC50 to an ap-
parent EC50 of about 4 WM. However, again, treat-
ment with 50 WM H89 did not change the kinetics of
the L3-AR-mediated cAMP production: the EC50
Fig. 1. E¡ect of H89 on PKA activity from brown adipocytes.
Brown adipocytes were isolated and cultured as described in
Section 2. They were stimulated with norepinephrine (NE) or
water (C), after which cell extracts were used for analysing
PKA activity. In each extract, 100% was de¢ned as the PKA
activity induced by addition of an excess of cAMP (5 WM).
(A) PKA activity after 5 min stimulation with the indicated NE
concentrations. The values are mean points from two experi-
ments with single wells. Curve is drawn according to simple Mi-
chaelis-Menten kinetics. (B) PKA activity after 5 min stimula-
tion with 1 WM NE. The resulting cell extracts were analysed
for PKA activity with or without addition of 50 WM H89. The
values are means þ S.E. from nine experiments for extracts with-
out H89 and four experiments for extracts with H89, all from
single wells. In the nontreated extracts, Student’s paired t-test
of the logarithmetised values, comparing control to NE, yielded
a signi¢cant e¡ect (P6 0.01) of NE treatment. Student’s paired
t-test of the logarithmetised values from parallel experiments,
comparing NE to H89+NE, yielded a signi¢cant inhibition
(P6 0.01) by H89 treatment.
6
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was 15 þ 7 nM (Fig. 3B). Thus, neither in the mem-
brane fractions nor in the cultured intact cells could
any L3-AR antagonism by H89 be detected.
Notably, the maximal e¡ect of BRL-37344 was
markedly potentiated by H89 in the intact cells,
with an increase of 4-fold over that induced by the
L3-AR agonist alone (Fig. 3A,B), an e¡ect which was
not present in the membrane fractions (Fig. 2A,B).
Similarly, cAMP production induced by NE or the
L3-AR agonist CGP-12177 [35] was also markedly
potentiated by H89 treatment in the cultured cells
(not shown). We have not clari¢ed the mechanisms
of this potentiating e¡ect by H89. However, since
this potentiating e¡ect is not present in the adrener-
gically stimulated membrane fractions, post-cyclase
mechanisms must be involved. In other systems,
PKA has been demonstrated to inhibit the activity
of certain adenylyl cyclase isoforms by about 50%
[36,37]. Thus, an attenuation by H89 of such an in-
hibitory PKA e¡ect may perhaps explain the massive
induction of cAMP production in the H89-treated
cells.
Taken together, these results demonstrate that
H89 has no antagonistic e¡ect on L3-AR-stimulated
cyclase activity, and H89 may even augment the re-
sulting cAMP levels. These results therefore also im-
ply that, in brown adipocytes, inhibitory e¡ects by
H89 must necessarily involve signalling mechanisms
downstream of cAMP.
3.4. E¡ect of H89 on adrenergically induced oxygen
consumption (thermogenesis)
To investigate whether adrenergically induced
thermogenesis in brown adipocytes is mediated via
PKA, we analysed the e¡ect of H89 on this process.
Isolated mature hamster brown adipocytes were
stimulated with NE, the endogenous thermogenic ac-
tivator, which potently stimulates oxygen consump-
tion ^ i.e. thermogenesis ^ in these isolated cells via
L3-ARs [1,2,38]. This stimulation can be mimicked
by cAMP-elevating agents [2].
As exempli¢ed in Fig. 4A, successive additions of
NE to isolated brown adipocytes generated, as ex-
pected, an approx. 10-fold increase in oxygen con-
Fig. 2. E¡ect of H89 on the kinetics of cAMP production
stimulated via L3-adrenoceptors in membrane fractions. Mem-
brane fractions were isolated from brown adipose tissue and
treated as indicated, after which cAMP levels were determined
as described in Section 2. The values are means from duplicate
incubation tubes for each treatment; individual values are indi-
cated with error bars. Curves were drawn according to simple
Michaelis-Menten kinetics. (A) cAMP levels after treatment
with BRL-37344 (BRL) for 10 min. EC50 was 141 þ 24 nM. (B)
cAMP levels after treatment with BRL as in A, but with 50 WM
H89 present. EC50 was 116 þ 8 nM. The arrow indicates the ex-
pected EC50 value if H89 had a Ki of 0.2 WM on the L3-AR.
C
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sumption. The mean EC50 under control conditions,
i.e. without H89, was 155 nM (Fig. 4C). When sim-
ilar experiments were performed in the presence of
di¡erent H89 concentrations (as exempli¢ed in Fig.
4B), no change in EC50 was observed (Fig. 4C).
Again, if H89 exerted a similar antagonism as for
the classical L-ARs, the EC50 should be shifted sev-
eral orders of magnitude (as illustrated in Fig. 4C,
dotted line).
Thus, in agreement with the results above for
cAMP generation in brown adipose tissue membrane
fractions (Fig. 2) and cultured brown adipocytes
(Fig. 3), these results also indicate that no L3-AR
antagonism was exerted by H89.
However, as is evident in Fig. 4B, H89 treatment
led to a marked inhibition of thermogenesis without
a¡ecting the basal metabolism of the cells. The oxy-
gen consumption was dose-dependently reduced by
H89 with an IC50 of about 40 WM (Fig. 4D). This
indicates that adrenergically induced thermogenesis
in brown adipocytes is mediated via PKA, which is
in agreement with expectations [5,6], but has not
been shown earlier. The IC50 of about 40 WM is of
a similar magnitude to that observed for cAMP-de-
pendent processes in other whole-cell systems, e.g. by
Chijiwa et al. [20].
In the presence of a high dose of H89 (160 WM),
the NE-induced oxygen consumption was practically
abolished (Fig. 4B). However, even under these con-
ditions, addition of the free fatty acid lauric acid,
which activates mitochondrial thermogenic processes
directly [28], still led to a fully potent increase in
oxygen consumption (Fig. 4B). This indicates that
the mitochondrial thermogenic processes were intact
in the cells, even at very high H89 concentrations.
In a similar series of experiments on brown adipo-
cytes isolated from mice, we obtained practically
identical results: no e¡ect of H89 on EC50 values
for NE, but an inhibitory e¡ect on the magnitude
of NE-induced thermogenesis, with an IC50 of about
30 WM, i.e. a response very similar to that shown in
Fig. 4D (not shown).
Thus, these results demonstrate that the pathway
for adrenergic activation of thermogenesis in brown
adipocytes is indeed L3-AR activation, elevation of
cAMP levels and activation of PKA.
Fig. 3. E¡ect of H89 on the kinetics of cAMP production
stimulated via L3-adrenoceptors in intact cells. Brown adipo-
cytes were isolated and cultured under conditions identical to
those in Fig. 1 and treated as indicated, after which the cells
were harvested and cAMP levels determined as described in
Section 2. The values are means þ S.E. from two experiments
with duplicate wells for each treatment. Curves were drawn ac-
cording to simple Michaelis-Menten kinetics. (A) cAMP levels
after stimulation with BRL-37344 (BRL) for 15 min. Maximal
increase was 80 þ 7 pmol/well with EC50 = 17 þ 7 nM. (B) cAMP
levels after stimulation with BRL as in A, but with 50 WM H89
added shortly before BRL. The values are from parallel wells
to those in A. Maximal increase was 337 þ 31 pmol/well with
EC50 = 15 þ 7 nM. The arrow indicates the expected EC50 value
if H89 had a Ki of 0.2 WM on the L3-AR.
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3.5. E¡ect of H89 on adrenergic stimulation of
UCP1 gene expression
As it was clear from the investigations above that
H89 did not have an antagonistic e¡ect on L3-ARs
and did not disturb general cell metabolism (see also
below), we found H89 to be a suitable tool also to
investigate the involvement of PKA in adrenergic
stimulation of expression of the brown adipocyte
speci¢c mitochondrial UCP1 gene. Adrenergic stim-
ulation of the expression of this gene is mediated via
L3-ARs and this e¡ect can be mimicked by increased
cAMP levels [3]. To examine further mediation via
PKA, cultured brown adipocytes were treated with
H89 and the e¡ect on adrenergically induced Ucp1
expression was analysed.
As expected, NE, and also the direct activator of
adenylyl cyclase, forskolin, were potent inducers of
Ucp1 expression (Fig. 5A,B). However, in H89-
treated cells, the stimulatory e¡ects of both NE
Fig. 4. E¡ect of H89 on the kinetics of adrenergically stimulated oxygen consumption. Mature brown adipocytes were freshly isolated
as described in Section 2 and treated with the indicated concentrations of H89 for 15 min. The cells then received cumulative addi-
tions of norepinephrine (NE), during which time oxygen consumption was measured as described in Section 2. (A) Recording of oxy-
gen consumption in control cells after additions of 1, 10, 100 nM, 1, 10 WM NE as indicated by arrows. (B) Recording of oxygen con-
sumption in the presence of 160 WM H89 with additions of 1 nM^100 WM NE and 5 mM lauric acid as indicated by arrows. (C)
EC50 values for NE-induced oxygen consumption in the presence of 0^80 WM H89. EC50 values were estimated from experiments as
in A and B by linear interpolation based on logarithmic NE concentration data (as oxygen consumption was practically abolished at
160 WM H89 (B), a meaningful EC50 value could not be obtained at this concentration). The values are means þ S.E. from two experi-
ments. (D) Basal and maximal NE-induced oxygen consumption in the presence of 0^160 WM H89. The values are means þ S.E. from
¢ve experiments for basal values and from two experiments for NE-induced values. a, basal oxygen consumption; b, maximal NE-in-
duced oxygen consumption. The curve was drawn according to simple Michaelis-Menten kinetics.
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and forskolin were fully abolished (Fig. 5A,B).
Although the inhibition by H89 of the NE e¡ect as
such could be understood either as an inhibition of
PKA or as an antagonism on the L3-AR, it is evident
that the e¡ect on forskolin-induced expression could
not be due to receptor antagonism. As H89 did not
decrease forskolin-induced cAMP levels (not shown),
the inhibition must be downstream of cAMP.
To con¢rm that no unspeci¢c detrimental e¡ects
on mRNA had occurred, the levels of L-actin mRNA
were also analysed. There were no signi¢cant e¡ects
of H89 treatment on L-actin mRNA levels (Fig. 5A),
and thus no general detrimental e¡ects on mRNA
had occurred during the time frame investigated
(100 min). Further, in these cells, adrenergic activa-
tion of extracellular signal-regulated kinases 1 and 2
(Erk 1/2) via the K1-AR pathway is una¡ected by 50
WM H89 [39], which indicates that other adrenergic
signalling mechanisms are still intact in H89-treated
brown adipocytes.
Although it has earlier been suggested that adre-
nergically induced Ucp1 expression is induced via
PKA activity [40,41], and although it has been dem-
onstrated that PKA (catalytic subunit) can mimic
adrenergically induced Ucp1 expression [7], this is
the ¢rst demonstration that the NE-induced increase
in UCP1 mRNA levels is indeed mediated via PKA.
H89 has been reported to inhibit the adrenergically
stimulated increase in UCP1 protein by about 50% in
transformed brown adipocytes [32], but in that sys-
tem, adrenergic stimulation did not induce PKA ac-
tivity [32].
Thus, the present results demonstrate that H89 is
functional within the primary brown adipocytes used
in this study by inhibiting pathways downstream of
cAMP, which are expected to progress through PKA
activation, such as adrenergically induced Ucp1 ex-
pression.
4. Discussion
4.1. H89 is not an antagonist on the L3-adrenoceptor
In the present study, we have investigated whether
PKA is involved in the adrenergically stimulated
pathways which activate thermogenesis and expres-
sion of the UCP1 gene in brown adipocytes. The
involvement of PKA in stimulation of these process-
es has been assumed earlier, but never directly dem-
onstrated. To investigate this assumed PKA involve-
ment, we used the PKA inhibitor H89. However, in
other cell systems, H89 has been demonstrated to
have potent adrenergic antagonistic potency for the
Fig. 5. E¡ect of H89 on adrenergic stimulation of UCP1 gene
expression. Brown adipocytes were cultured under conditions
identical to those in Fig. 1. On day 6, the cells were treated or
not with 50 WM H89 for 40 min and thereafter stimulated, as
indicated, for 1 h, after which the cells were harvested and
RNA was isolated for Northern blot analysis as described in
Section 2. C, control; NE, 10 WM norepinephrine; Fsk, 10 WM
forskolin. (A) Northern blot resulting from treatment as indi-
cated. Upper panel shows signals for UCP1 mRNA. Lower
panel shows signals for L-actin mRNA in the same lanes. (B)
UCP1 mRNA levels after stimulation as indicated. The values
are means þ S.E. from one experiment with quadruplicate wells
for each treatment. The mean value of NE-treated cells was set
to 100%. The full abolishment by H89 of the NE e¡ect was re-
produced in two other independent experiments under identical
conditions.
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classical L-ARs, L1 and L2 [22]. In order to evaluate
the usefulness of H89 for investigations on L3-AR
signalling pathways, it was therefore necessary to in-
vestigate whether H89 had antagonistic potency also
for the L3-ARs. Our investigation demonstrates that
the kinetics (EC50) of L3-AR-mediated stimulation of
cAMP production in brown adipose tissue mem-
brane fractions and intact brown adipocytes were
una¡ected by high concentrations of H89. Similarly,
the EC50 of adrenergically induced oxygen consump-
tion in intact cells was not signi¢cantly a¡ected by
H89. It is clear that if an antagonistic activity of H89
on L3-ARs were to exist, with a reasonably low Ki
(high a⁄nity), as has been shown for the classical L-
ARs, the kinetics of the L3-AR-mediated e¡ects in-
vestigated here would have been markedly a¡ected,
with increases in the apparent EC50 values of several
orders of magnitude (as illustrated in Fig. 2B, 3B and
4C). As no such e¡ect was seen, our results demon-
strate that no antagonism was exerted by H89 on L3-
ARs.
Apparently, the agonist binding site on L1- and L2-
ARs is su⁄ciently di¡erent from that on L3-ARs to
allow high a⁄nity binding of H89 to the former, but
not to the latter. Of course, the marked pharmaco-
logical di¡erences between L3-ARs and L1/L2-ARs,
that allowed for their pharmacological distinction
[42], are congruent with such a di¡erence in the bind-
ing a⁄nities for H89. Thus, the restricted usefulness
of H89 for the classical L-ARs does not apply to L3-
ARs.
4.2. Adrenergic induction of thermogenesis and
Ucp1 expression is PKA-mediated
In the present study, we demonstrate that certain
adrenergically induced processes (thermogenesis and
UCP1 gene expression) in brown adipocytes were
inhibited by H89 and therefore conclude that these
processes are mediated via PKA activation.
Rather high concentrations of H89 (about 50 WM)
were used in the experiments to observe this inhibi-
tion. A lower dose (10 WM) was also able to inhibit
e.g. adrenergically induced Ucp1 expression, but the
inhibitory e¡ect was not complete (not shown). As
the mechanism of action of H89 (and other isoqui-
nolinesulphonamides) is as a competitive inhibitor
with ATP on the active site of PKA [20,43], the ne-
cessity for a high concentration of H89 is what could
be expected. The a⁄nity of ATP for the catalytic site
is about 5 WM, and the Ki of H89 for this site is
about 50 nM [20,43]. Thus, even with an H89 con-
centration of 50 WM, the apparent a⁄nity of PKA
for ATP would only be decreased to about 5 mM
(5 WMU(1+(50 WM/50 nM))). With an intracellular
ATP concentration in the millimolar range even this
increase in apparent EC50 would theoretically hardly
be su⁄cient to fully inhibit endogenous PKA activa-
tion. Thus, it is clear that H89 concentrations in the
order of magnitude used here are necessary for PKA
inhibition within intact cells (in agreement with ob-
servations in other cell types [20]).
Many adrenergic e¡ects in brown adipocytes can
be mimicked by cAMP and have therefore been im-
plied to be mediated by PKA, but evidence for this
has been only circumstantial. That an adrenergic ef-
fect is mimicked by an agent does not necessarily
indicate that this agent is the physiological mediator
of the adrenergic stimulation, and it is now recog-
nised that not all cAMP e¡ects are PKA mediated
[10^19]. No evidence has been presented until now
that establishes endogenous cAMP/PKA involve-
ment in the mediation of these L3-AR e¡ects in
brown adipocytes. The demonstration here that inhi-
bition of adrenergically induced PKA activity abol-
ishes adrenergically induced thermogenesis and ex-
pression of Ucp1 is thus the ¢rst time it is
established that the sequential signalling pathway
for these processes is indeed L3-AR activation,
cAMP elevation and PKA activation. However, as
with any inhibitor, H89 may not be fully speci¢c
for its intended target. In this context, it was recently
demonstrated that H89 is also an inhibitor of kinases
other that PKA, such as MSK1, ROCK-II and S6K1
[44], but based on the activation pathways demon-
strated for these kinases, none of these other kinases
are likely to be associated with adrenergic stimula-
tion of Ucp1 expression or thermogenesis. The most
likely conclusion of the results in this study, and fully
compatible with these results, is mediation of the ad-
renergic stimulation via PKA.
The downstream targets of the activated PKA in
these cells may be of diverse nature. There may be
direct activation of enzymes, such as hormone-sensi-
tive lipase, the activation of which probably results in
stimulation of lipolysis and thereby induces thermo-
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genesis [5,28]. There may be direct activation of tran-
scription factors such as cAMP-responsive element-
binding protein (CREB) [41] (Thonberg et al., un-
published data) which is probably the mediator of
adrenergically induced Ucp1 expression [7,40,41].
Also, further signalling cascades may be adrenergi-
cally activated via PKA, such as the Src tyrosine ki-
nase-Erk1/2 mitogen-activated protein (MAP) kinase
cascade [39] with its pronounced e¡ects on cellular
destiny.
4.3. Conclusions
We have demonstrated here that H89 inhibits ad-
renergic activation of thermogenesis and Ucp1 ex-
pression in brown adipocytes and that H89 does
not inhibit these physiologically relevant e¡ects of
adrenergic agonists via L3-AR antagonism. Rather,
all data indicate that H89 functions via an inhibitory
e¡ect downstream of cAMP, i.e. by inhibition of
induced PKA activity. We thus conclude that H89
may be used for the elucidation of PKA-dependent
signalling mechanisms in cell systems which entopi-
cally express L3-ARs, and that PKA has indeed an
essential role in brown adipose tissue function by
mediating adrenergic stimulation of thermogenesis
and Ucp1 expression.
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